Education
About Us
Working with TipRanks
Follow Us
Santhosh Palani Insider Profile
4 Followers
Santhosh Palani, Director at Acrivon Therapeutics, Inc., holds ― shares in Acrivon Therapeutics, Inc. (Ticker: ACRV), holds 6.00K shares in Pyxis Oncology (Ticker: PYXS). Most recently, Santhosh Palani ― shares of Acrivon Therapeutics, Inc. on ― for an estimated value of ―.
Santhosh Palani has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Santhosh Palani holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Santhosh Palani
Santhosh Palani's Trading History
Acrivon Therapeutics, Inc.
―
Director
―
―
Pyxis Oncology
Jun 07, 2024
Director
Uninformative Buy
―
$6.96K
List of latest transactions for each holding click on a transaction to see Santhosh Palani's performance on stock
You May Also Like
Santhosh Palani insider profile FAQ
What is the percentage of profitable transactions made by Santhosh Palani?
The percentage of profitable transactions made by Santhosh Palani is ―.
What is the average return per transaction made by Santhosh Palani?
The average return per transaction made by Santhosh Palani is ―.
What stocks does Santhosh Palani hold?
Santhosh Palani holds: ACRV, PYXS stocks.
What was Santhosh Palani’s latest transaction?
Santhosh Palani latest transaction was an Uninformative Buy of ―.
What was Santhosh Palani's most profitable transaction?
Santhosh Palani’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Santhosh Palani's role in Acrivon Therapeutics, Inc.?
Santhosh Palani's role in Acrivon Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.